The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Lipolytic action of glucagon-like peptides in isolated rat adipocytes
Abstract
The lipolytic effect of GLP-1(1-36)-amide, GLP-1(7-36) amide and GLP-2 [proglucagon(126-159)] has been studied in isolated rat adipocytes. Glycerol release and cyclic AMP content were measured after incubation of adipocytes with GLPs and results have been compared with those obtained in the presence of glucagon. GLP-1(7-36)-amide and GLP-1(1-36)-amide at 10(-8), 10(-7) and 10(-6) M concentrations activated glycerol release, the truncated peptide having a more potent effect. On the other hand, GLP-2 had no effect on glycerol release. Also, it has been found that 10(-6) M GLP-1(7-36)-amide increases cyclic AMP content in adipocytes and does not compete with glucagon binding. These results demonstrate that GLP-1(7-36)-amide has a lipolytic effect on isolated rat adipocytes through different receptors than glucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to experimental research, GLP-1 can certainly cause both lipogenic and lipolytic effects in a dose-dependent manner, with lipogenic action predominating at picomolar concentrations and lipolytic action at nanomolar doses [59,60,61,62,63].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [59]
Citations
Cites
Metabolism of Isolated Fat Cells
Rodbell, M. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51687-2 · Cited by 4,427
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.
Rodbell, M. (1964) · PubMed · Cited by 1,387
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Hamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649
Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
Holst, J. J., Ørskov, C., Vagn Nielsen, O., & Schwartz, T. W. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81430-8 · Cited by 615
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
ØRSKOV, C., HOLST, J. J., & NIELSEN, O. V. (1988) · Endocrinology · doi:10.1210/endo-123-4-2009 · Cited by 396
Glucagonlike Peptide I (7–37) Actions on Endocrine Pancreas
Weir, G. C., Mojsov, S., Hendrick, G. K., & Habener, J. F. (1989) · Diabetes · doi:10.2337/diab.38.3.338 · Cited by 275
Mammalian pancreatic preproglucagon contains three glucagon-related peptides.
Lopez, L. C., Frazier, M. L., Su, C. J., Kumar, A., & Saunders, G. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5485 · Cited by 234
Research works printed but not linked: 1
- Wieland, 1957, Eine enzymatische Methode zur Bestimmung von Glycerin, Biochem. Z., 329, 313
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
“Nevertheless, GLP-1 treatment of isolated rat adipocytes increased lipolysis (85) and exogenous GLP-1 exerted both lipolytic and lipogenic effects in human adipocytes (86).”
BackgroundFEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528
Metadata
- Authors
- Ruiz-Grande, C., Alarcón, C., Mérida, E., & Valverde, I.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Valverde, Isabel
- ORCID
- Alarcón, Cristina
- Venue
- Peptides
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 1
- Pages
- 13-16
- ISSN
- 0196-9781 (ISSN-L)
- OpenAlex
- W2031055048
- Cited by
- 89
- References
- 28
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2021: 1 · 2020: 4 · 2019: 2 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Peptides (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide, GLP-1(7-36)amide, glucagon-like peptide-2, adipocytes, lipolysis, glycerol release, cyclic AMP, glucagon, proglucagon, peptide receptors, rats
- MeSH terms
- Cyclic AMP, Adipose Tissue, Animals, Dose-Response Relationship, Drug, Glucagon-Like Peptides, Epididymis, Glucagon, Glycerol, Lipolysis, Male, Peptide Fragments, Peptides, Receptors, Gastrointestinal Hormone, Receptors, Glucagon, Rats, Glucagon-Like Peptide 1, Glucagon-Like Peptide 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipolytic action of glucagon-like peptides in isolated rat adipocytes. https://app.cochat.ai/papers/10.1016/0196-9781(92)90134-o
- The paper
- Ruiz-Grande, C., Alarcón, C., Mérida, E., & Valverde, I. (1992). Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides. https://doi.org/10.1016/0196-9781(92)90134-o
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.